Results 211 to 220 of about 17,288 (263)
Some of the next articles are maybe not open access.
Desmopressin in Nocturnal Enuresis
Journal of Urology, 1991The effect of intranasal desmopressin on primary nocturnal enuresis was investigated in a study divided into 2 parts in which the first part was a randomized, double-blind, placebo-controlled cross-over study of 52 Finnish school children 5 to 13 years old.
openaire +3 more sources
Neurourology and Urodynamics, 2019
To systematically assess all available evidence on efficacy and safety of desmopressin for treating nocturia in patients with multiple sclerosis (MS).
V. Phé +7 more
semanticscholar +1 more source
To systematically assess all available evidence on efficacy and safety of desmopressin for treating nocturia in patients with multiple sclerosis (MS).
V. Phé +7 more
semanticscholar +1 more source
2001
Noniatrogenic Cushing’s syndrome is a rare clinical entity that is caused by an inappropriately elevated endogenous cortisol production and results in significant morbidity and mortality in affected patients. Despite its rarity, Cushing’s syndrome represents one of the most challenging diseases in clinical endocrinology because, despite the use of a ...
S. Tsagarakis, N. Thalassinos
openaire +2 more sources
Noniatrogenic Cushing’s syndrome is a rare clinical entity that is caused by an inappropriately elevated endogenous cortisol production and results in significant morbidity and mortality in affected patients. Despite its rarity, Cushing’s syndrome represents one of the most challenging diseases in clinical endocrinology because, despite the use of a ...
S. Tsagarakis, N. Thalassinos
openaire +2 more sources
Journal of Pediatric Urology
Desmopressin is well accepted as first-line medical therapy for enuresis. If ineffective, combination therapy of desmopressin + oxybutynin or desmopressin + imipramine has been used. This study assessed the efficacy of adjunct therapy with either imipramine or oxybutynin in the management of enuresis patients who failed desmopressin treatment.A ...
Spencer Shain +12 more
openaire +2 more sources
Desmopressin is well accepted as first-line medical therapy for enuresis. If ineffective, combination therapy of desmopressin + oxybutynin or desmopressin + imipramine has been used. This study assessed the efficacy of adjunct therapy with either imipramine or oxybutynin in the management of enuresis patients who failed desmopressin treatment.A ...
Spencer Shain +12 more
openaire +2 more sources
Desmopressin for the treatment of haemophilia
Haemophilia, 2007Summary. The synthetic vasopressin analogue (1–deamino‐8‐d‐arginine‐vasopressin) increases plasma concentration of factor VIII and von Willebrand factor in normal subjects and patients with mild haemophilia A and von Willebrand disease. Since its first clinical use in 1977, desmopressin has become the treatment of choice for patients with haemophilia ...
openaire +3 more sources
FDA Approval of Desmopressin for Nocturia
JAMA, 2017On March 3, 2017, the US Food and Drug Administration (FDA) approved desmopressin nasal spray (Noctiva) for the “treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void.”1 According to the product manufacturer, Serenity Pharmaceuticals, nocturia is a common condition affecting “over 89 million adults in ...
Aaron S. Kesselheim, Michael Fralick
openaire +3 more sources
Desmopressin for nocturia in adults
Drug and Therapeutics Bulletin, 2017Desmopressin has been used for many years in the treatment of diabetes insipidus, nocturnal enuresis (involuntary urination while asleep) and nocturia associated with multiple sclerosis (in adults aged up to 65 years); it has also been recommended in certain circumstances for the treatment of nocturia in men and women (previously, an unlicensed use).1 ...
openaire +2 more sources
Stability of Desmopressin Loaded in Liposomes
Journal of Liposome Research, 2003Desmopressin-containing liposome formulations have been developed for intranasal administration previously. Positively charged liposomes were found to be an efficient delivery system for desmopressin. In this study, stability of the loaded desmopressin in positively charged liposomes was further investigated. Comparison of the stability of desmopressin
K. J. Huang, V. H. Y. Chou, S. L. Law
openaire +3 more sources
Intranasal Desmopressin in Mild Hemophilia A
Annals of Internal Medicine, 1985Excerpt To the editor: Recently, de la Fuente and coworkers (1) confirmed that intravenous administration of desmopressin to persons with mild or moderate hemophilia is useful in the management of ...
Ignacio Alberca +3 more
openaire +3 more sources